Merck (MRK)

$94.66 1.51 (1.60%)

19:00 EST MRK Stock Quote Delayed 30 Minutes

Big Pharma Banking on New Cancer Treatment Approach to Boost Sales

By Barry Cohen, Health Care Writer Aug 15, 2011

GlaxoSmithKline, Eli Lilly and Novartis are among the companies studying epigenetics -- a new approach to fighting cancer that is already seeing some success.

Dow Jones Jettisons 300 Points Early Monday

Kraft Spins Off Snacks, Wisely Bucking 2011 Buyout Boom

Merck Shares — 3 Pros, 3 Cons

Volume:

Previous Close $92.25

Market Cap 235.30B

PE Ratio 14.05

EPS 6.7363

Volume (Avg. Vol.) 12.30M

Day's Range $91.78 - $93.21

52-Week Range $81.04 - $132.70

Dividend & Yield $3.12 (3.30%)

MRK Stock Predictions, Articles, and Merck News

Caterpillar Plods Ahead as Dow Jones Dips

By Jonathan Yates, InvestorPlace Contributor Aug 1, 2011

Positive analyst recommendations send Caterpillar up about 2.4% in early morning trading; Dow Jones stocks Home Depot, Merck and Disney drop.

Deep-Pocket Drug Companies Poised to Reap Biosimilar Rewards

By Barry Cohen, Health Care Writer Jul 25, 2011

Only a few companies have the massive resources needed to get going in the upcoming "biosimilars" boom. Who will lead the charge?

Should You Buy Medco Health?

By Peter Cohan, InvestorPlace Writer Jul 22, 2011

Buyout offer from Express Scripts makes this an interesting stock, but absent a bidding war, you might be better off avoiding MHS

Dow Fights Back from Brink, Thanks to Google and Oil Stocks

By Jonathan Yates, InvestorPlace Contributor Jul 15, 2011

Facing its worst week in a year, the Dow Jones Industrial Average rose in the morning session, bolstered by strong earnings from Google (NASDAQ: GOOG) and Citi (NYSE: C), to rise about 15.40 points to over 12542, a gain of more than 15%.

Low U.S. Hiring Hounds Alcoa, CAT and Dupont

By Jonathan Yates, InvestorPlace Contributor Jul 8, 2011

Industrials Alcoa, Caterpillar and DuPont all down about 2% in early trading; Merck a lone bright spot for Dow.

4 Health Care Stocks That Are the Prescription for a Perfect Portfolio

By Hilary Kramer, Editor, GameChangers Jul 7, 2011

For the long haul, the prospects for health care stocks are promising -- and not just as a defensive play. These four picks are just what the doctor ordered.

ObamaCare Court Test a Non-event for Health Stocks

By Barry Cohen, Health Care Writer Jul 5, 2011

Health insurance, pharmaceutical companies' gains show confidence that ObamaCare is all but a done deal.

Techs and European Debt Woes Weigh Down Dow

By Kyle Woodley, Senior Investing Editor, Kiplinger Jun 24, 2011

Tech stocks Oracle, Micron, Microsoft, Cisco bring Dow down in early trading, and Big Pharma's Pfizer off; consumer stocks up slightly.

Fidelity Select Pharmaceutical Mutual Fund Offers Diversified Drug Play

By Cynthia Wilson, Consumer Finance & Funds Writer Jun 16, 2011

The Fidelity Select Pharmaceutical Portfolio offers a diversified group of big pharma stocks and biotech investments that give investors a way to play the entire sector easily.

ISE Plans to Change Trading System

By OptionsZone Experts Jun 13, 2011

The International Securities Exchange plans to modify its market maker system.

Could Legalized Pot Give Big Pharma a Much-Needed Boost?

By Barry Cohen, Health Care Writer May 31, 2011

Medical marijuana is big business where it's legalized, and if major pharmaceutical companies could get a share of the market they could see a big boost.

Vertex vs. Merck in Hepatitis Drug Title Fight

By Barry Cohen, Health Care Writer May 25, 2011

All that's at stake is a $10 billion market.

How to Fix the Dow – 3 Stocks to Drop & 3 to Add

By Jeff Reeves May 19, 2011

May 26 marks 115th birthday of the Dow Jones Industrial Average. Jeff Reeves suggests 3 stocks to drop and 3 to add to improve the accuracy of the index.